Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 725, pseudogene (RN7SL725P) is a *processed pseudogene* in the human genome, highly similar to the functional 7SL RNA gene but lacking protein-coding or regulatory activity due to truncations and mutations[1][5]. The parental 7SL RNA is an essential non-coding RNA of the Signal Recognition Particle, involved in targeting secretory proteins to the endoplasmic reticulum in eukaryotic cells[3][7][9]. The genome contains hundreds of 7SL-like pseudogenes generated by reverse transcription and sequence integration, but only a small number encode functional RNAs[5]. RN7SL725P and similar pseudogenes are generally transcriptionally inactive or produce nonfunctional RNA fragments[1][8]. Some processed pseudogenes may theoretically regulate parental gene expression through ceRNA/miRNA sponge mechanisms, but there is no evidence that RN7SL725P is active in this way[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 725, pseudogene (RN7SL725P).